Total Payments
$3,726
2024 Payments
$1,188
Companies
18
Transactions
177
Medicare Patients
1,363
Medicare Billing
$88,257
Payment Breakdown by Category
Food & Beverage$3,486 (93.6%)
Education$239.20 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,486 | 174 | 93.6% |
| Education | $239.20 | 3 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $594.55 | 29 | $0 (2024) |
| ABBVIE INC. | $577.54 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $431.53 | 24 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $285.57 | 11 | $0 (2024) |
| GENZYME CORPORATION | $277.20 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $251.42 | 10 | $0 (2024) |
| Incyte Corporation | $251.21 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $236.42 | 10 | $0 (2024) |
| LEO Pharma Inc. | $210.64 | 14 | $0 (2024) |
| Lilly USA, LLC | $205.66 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,188 | 61 | Regeneron Healthcare Solutions, Inc. ($187.32) |
| 2023 | $1,060 | 45 | ABBVIE INC. ($198.54) |
| 2022 | $1,002 | 47 | Janssen Biotech, Inc. ($164.93) |
| 2021 | $475.60 | 24 | Janssen Biotech, Inc. ($200.73) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Immunology | ||||||
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Immunology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Immunology | ||||||
| 10/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $99.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: DERMATOLOGY | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Dermatology | ||||||
| 07/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DERMATOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Dermatology | ||||||
| 06/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 395 | 630 | $72,680 | $24,820 |
| 2022 | 8 | 364 | 564 | $69,482 | $24,099 |
| 2021 | 9 | 363 | 659 | $65,322 | $25,998 |
| 2020 | 7 | 241 | 323 | $32,198 | $13,339 |
Total Patients
1,363
Total Services
2,176
Medicare Billing
$88,257
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 161 | $24,129 | $9,025 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 65 | $13,634 | $4,978 | 36.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 58 | 67 | $14,158 | $4,474 | 31.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 67 | 82 | $10,450 | $2,712 | 26.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 30 | 31 | $5,425 | $1,662 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,604 | $1,119 | 43.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 46 | 210 | $2,280 | $850.37 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 110 | $14,190 | $6,583 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 71 | $13,277 | $5,385 | 40.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 48 | 55 | $10,780 | $3,707 | 34.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 60 | 71 | $14,200 | $2,451 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $7,075 | $2,306 | 32.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 25 | 28 | $4,928 | $1,727 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,162 | $1,067 | 33.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 39 | 187 | $1,870 | $874.57 | 46.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 68 | $12,716 | $5,788 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 106 | $13,674 | $5,651 | 41.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 50 | 64 | $12,544 | $4,429 | 35.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 55 | 79 | $6,641 | $2,727 | 41.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 29 | 36 | $6,336 | $1,977 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,679 | $1,463 | 39.8% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 11 | 13 | $3,588 | $1,425 | 39.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $3,534 | $1,319 | 37.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 42 | 261 | $2,610 | $1,221 | 46.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 80 | $12,440 | $5,254 | 42.2% |
About Lynn Williams, PA-C
Lynn Williams, PA-C is a Medical healthcare provider based in Villanova, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346298601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lynn Williams, PA-C has received a total of $3,726 in payments from pharmaceutical and medical device companies, with $1,188 received in 2024. These payments were reported across 177 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,486).
As a Medicare-enrolled provider, Williams has provided services to 1,363 Medicare beneficiaries, totaling 2,176 services with total Medicare billing of $88,257. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Villanova, PA
- Active Since 05/05/2006
- Last Updated 05/14/2018
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1346298601
Products in Payments
- DUPIXENT (Biological) $528.62
- TREMFYA (Drug) $409.09
- OPZELURA (Drug) $251.21
- SKYRIZI (Biological) $239.34
- Sotyktu (Drug) $236.42
- COSENTYX (Drug) $224.85
- ADBRY (Biological) $210.64
- RINVOQ (Biological) $206.42
- Winlevi (Drug) $193.03
- REMICADE (Biological) $185.46
- COSENTYX (Biological) $183.22
- TALTZ (Drug) $179.76
- EUCRISA (Drug) $112.58
- Otezla (Drug) $102.69
- ILUMYA (Biological) $92.54
- HUMIRA (Biological) $57.71
- VRAYLAR (Drug) $56.52
- VTAMA (Drug) $32.37
- Cabtreo (Drug) $28.87
- OLUMIANT (Drug) $25.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.